Subcutaneous implantable cardioverter-defibrillator and drug-induced Brugada syndrome: the importance of repeat morphology analysis during ajmaline challenge

Eur Heart J. 2016 May 14;37(19):1498. doi: 10.1093/eurheartj/ehv572. Epub 2015 Nov 3.

Authors

Giulio Conte¹, Francois Regoli², Tiziano Moccetti², Angelo Auricchio²

Affiliations

¹ Cardiocentro Ticino, Lugano, Switzerland giulio.conte@cardiocentro.org.
² Cardiocentro Ticino, Lugano, Switzerland.

PMID: 26530106
DOI: 10.1093/eurheartj/ehv572

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Ajmaline / adverse effects
Anti-Arrhythmia Agents / adverse effects
Brugada Syndrome / chemically induced*
Defibrillators, Implantable*
Electrocardiography
Female
Heart Arrest / etiology*
Humans
Patient Positioning
Ventricular Fibrillation / drug therapy

Substances

Anti-Arrhythmia Agents
Ajmaline